Clinical Trials
1,055 trialsORCA-2
University College, London
Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma
Providence Health & Services
EACH
University College, London
Propolis for Radiotherapy-Induced Oral Mucositis in Head and Neck Cancer
Ankara Oncology Research and Training Hospital
MISORL
University Hospital, Bordeaux
Training Swallowing Initiation During Expiration
Northwestern University
A Randomized, Double-Blind Phase II Study of Adjuvant Pembrolizumab Versus Placebo in Head and Neck Cancers at High Risk for Recurrence- the PATHWay Study
University of Chicago
Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma
Washington University School of Medicine
Study Evaluating the Efficacy of Niraparib and Dostarlimab (TSR-042) in Recurrent/Metastatic HNSCC
University of Cincinnati
A Study to Test Different Doses of BI 765049 Alone and in Combination With Ezabenlimab in Asian People With Advanced Cancer (Solid Tumours) Positive for B7-H6
Boehringer Ingelheim
Adjuvant Nivolumab After Salvage Resection in Head and Neck Cancer Patients Previously Treated With Definitive Therapy
University of Cincinnati
PaRTNer
Duke University
A Pilot Study Evaluating the Effect of 2D Antiscatter Grids on CBCT Image Quality
University of Colorado, Denver
EffEx-HN
Universitaire Ziekenhuizen KU Leuven
Evaluation of On-Couch CBCT Image Quality
Varian, a Siemens Healthineers Company
Perineal Massage in Women With Gynecological Cancer
University of Alcala
ATHENA
Centre Leon Berard
Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Alcohol Cessation Among Head and Neck Cancer Survivors
Northwell Health
Perioperative Nutritional Optimization in Head and Neck Cancer Patients
University of Illinois at Chicago
TEC-ORL
Institut Claudius Regaud
RAMPART
Montefiore Medical Center
A Simple Walking Program to Enhance Concurrent Chemoradiotherapy Delivery
Montefiore Medical Center
eXcision
University Hospitals Coventry and Warwickshire NHS Trust
BD4QoL
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
OPTINOSE
Centre Antoine Lacassagne
TORS
Gustave Roussy, Cancer Campus, Grand Paris
FIT4TREAT
Associacao de Investigacao de Cuidados de Suporte em Oncologia
Proton Re-Irradiation for Recurrent Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
DARTBOARD
University of Texas Southwestern Medical Center
Study of DF6215 in Patients With Advanced Solid Tumors
Dragonfly Therapeutics
Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
DIREKHT
University of Erlangen-Nürnberg Medical School
KETOCOL
Centre Oscar Lambret
ALTAKRA-1405
Centre Oscar Lambret
Total-Body FDG PET for Radiotherapy Response Assessment in Head and Neck Cancer
University of California, Davis
Pilot Study of Radiation-Induced Xerostomia Treatment With Allogeneic Mesenchymal Stromal Stem Cells
Institute of Oncology Ljubljana
Cisplatin With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic or Recurrent Head and Neck Cancer
Eastern Cooperative Oncology Group
ACUPUNCTURE
Wake Forest University Health Sciences
UNOS
Institute of Oncology Ljubljana
Flexible Intubation Scope With or Without Video Laryngoscope in Supporting Endotracheal Tube Placement in Patients With Head and Neck Cancer Before Surgery
M.D. Anderson Cancer Center
Fecal Microbiota And Metabolites In Head And Neck Cancer Patients Receiving (Chemo)Radiotherapy
Institute of Oncology Ljubljana
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
Kaltenborn Versus Active Release on Temporomandibular Joint Dysfunction
MTI University
Effect of Prolonged Nightly Fasting on Immunotherapy Outcomes in HNSCC - Role of Gut Microbiome
H. Lee Moffitt Cancer Center and Research Institute
MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers
Adaptimmune
KEYNOTE-412
Merck Sharp & Dohme LLC
Hypofractionated Radiotherapy in Elderly Patients With Head & Neck Squamous Cell Carcinoma
Icahn School of Medicine at Mount Sinai
A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface
Boehringer Ingelheim
Effects of a Home-Based Exercise Program During Radiotherapy
Karadeniz Technical University